Target Price | $79.50 |
Price | $72.10 |
Potential | 10.26% |
Number of Estimates | 20 |
20 Analysts have issued a price target Coca-Cola 2026 . The average Coca-Cola target price is $79.50. This is 10.26% higher than the current stock price. The highest price target is $85.00 17.89% , the lowest is $70.00 2.91% . | |
A rating was issued by 26 analysts: 22 Analysts recommend Coca-Cola to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Coca-Cola stock has an average upside potential 2026 of 10.26% . Most analysts recommend the Coca-Cola stock at Purchase. |
18 Analysts have issued a sales forecast Coca-Cola 2025 . The average Coca-Cola sales estimate is $48.1b . This is 2.62% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $48.6b 3.70% , the lowest is $47.3b 0.96% .
This results in the following potential growth metrics:
2024 | $47.1b | 2.86% |
---|---|---|
2025 | $48.1b | 2.25% |
2026 | $50.7b | 5.30% |
2027 | $53.5b | 5.66% |
2028 | $55.3b | 3.22% |
13 Analysts have issued an Coca-Cola EBITDA forecast 2025. The average Coca-Cola EBITDA estimate is $16.1b . This is 25.44% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $16.6b 28.88% , the lowest is $14.5b 12.40% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $12.1b | 8.60% |
---|---|---|
2025 | $16.1b | 33.11% |
2026 | $17.4b | 8.00% |
2027 | $18.9b | 8.45% |
2028 | $20.2b | 6.84% |
2024 | 25.76% | 11.14% |
---|---|---|
2025 | 33.53% | 30.18% |
2026 | 34.39% | 2.56% |
2027 | 35.29% | 2.62% |
2028 | 36.53% | 3.51% |
8 Coca-Cola Analysts have issued a net profit forecast 2025. The average Coca-Cola net profit estimate is $12.7b . This is 17.62% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $13.0b 20.13% , the lowest is $12.0b 11.09% .
This results in the following potential growth metrics and future Net Margins:
2024 | $10.6b | 0.77% |
---|---|---|
2025 | $12.7b | 19.32% |
2026 | $13.8b | 8.83% |
2027 | $14.9b | 8.06% |
2028 | $16.2b | 8.81% |
2024 | 22.59% | 3.53% |
---|---|---|
2025 | 26.36% | 16.69% |
2026 | 27.24% | 3.34% |
2027 | 27.86% | 2.28% |
2028 | 29.37% | 5.42% |
8 Analysts have issued a Coca-Cola forecast for earnings per share. The average Coca-Cola EPS is $2.95 . This is 18.00% higher than earnings per share in the financial year 2024. The highest EPS forecast is $3.01 20.40% , the lowest is $2.78 11.20% .
This results in the following potential growth metrics and future valuations:
2024 | $2.46 | 0.40% |
---|---|---|
2025 | $2.95 | 19.92% |
2026 | $3.21 | 8.81% |
2027 | $3.47 | 8.10% |
2028 | $3.77 | 8.65% |
Current | 28.84 | 16.29% |
---|---|---|
2025 | 24.46 | 15.19% |
2026 | 22.48 | 8.09% |
2027 | 20.80 | 7.47% |
2028 | 19.12 | 8.08% |
Based on analysts' sales estimates for 2025, the Coca-Cola stock is valued at an EV/Sales of 7.18 and an P/S ratio of 6.45 .
This results in the following potential growth metrics and future valuations:
Current | 7.37 | 16.06% |
---|---|---|
2025 | 7.18 | 2.53% |
2026 | 6.82 | 5.04% |
2027 | 6.46 | 5.36% |
2028 | 6.25 | 3.12% |
Current | 6.62 | 14.17% |
---|---|---|
2025 | 6.45 | 2.56% |
2026 | 6.12 | 5.04% |
2027 | 5.80 | 5.36% |
2028 | 5.62 | 3.12% |
Analyst | Rating | Action | Date |
---|---|---|---|
RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 30 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 30 2025 |
JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Apr 21 2025 |
UBS |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
Piper Sandler |
Overweight
➜
Overweight
|
Unchanged | Feb 28 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 13 2025 |
Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Feb 12 2025 |
Analyst Rating | Date |
---|---|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Apr 30 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 30 2025 |
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Apr 21 2025 |
Unchanged
UBS:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
Piper Sandler:
Overweight
➜
Overweight
|
Feb 28 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 13 2025 |
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Feb 12 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.